Estimates Revisions Abbott Laboratories Sao Paulo
Stocks
ABTT34
BRABTTBDR007
Medical Equipment, Supplies & Distribution
|
Delayed
Sao Paulo
12:43:18 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 41.17 BRL | -17.25% |
|
-3.79% | -28.40% |
| 08:14am | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 10-05 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Abbott Laboratories(ABT)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Abbott Laboratories(ABT)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Abbott Laboratories(ABT)
EBIT
Dividend / Share (DPS)
Data source:
Abbott Laboratories(ABT)
Cash or Net Debt
- Stock Market
- Stocks
- ABT Stock
- ABTT34 Stock
- Consensus Abbott Laboratories
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
